[go: up one dir, main page]

EE200200479A - Eksemestaani kasutamine rinnavähi ravis - Google Patents

Eksemestaani kasutamine rinnavähi ravis

Info

Publication number
EE200200479A
EE200200479A EEP200200479A EEP200200479A EE200200479A EE 200200479 A EE200200479 A EE 200200479A EE P200200479 A EEP200200479 A EE P200200479A EE P200200479 A EEP200200479 A EE P200200479A EE 200200479 A EE200200479 A EE 200200479A
Authority
EE
Estonia
Prior art keywords
exemestane
treatment
breast cancer
breast
cancer
Prior art date
Application number
EEP200200479A
Other languages
English (en)
Estonian (et)
Inventor
Massimini Giorgio
Paridaens Robert
Lobelle Jean-Pierre
Piscitelli Gabriella
Original Assignee
Pharmacia Italia S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia S.P.A. filed Critical Pharmacia Italia S.P.A.
Publication of EE200200479A publication Critical patent/EE200200479A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EEP200200479A 2000-03-03 2001-02-20 Eksemestaani kasutamine rinnavähi ravis EE200200479A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0005257.1A GB0005257D0 (en) 2000-03-03 2000-03-03 Breast cancer hormonal therapy
PCT/EP2001/001883 WO2001064193A2 (en) 2000-03-03 2001-02-20 Exemestane for first-line treatment of breast cancer

Publications (1)

Publication Number Publication Date
EE200200479A true EE200200479A (et) 2003-12-15

Family

ID=9886975

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200479A EE200200479A (et) 2000-03-03 2001-02-20 Eksemestaani kasutamine rinnavähi ravis

Country Status (21)

Country Link
US (1) US20030144259A1 (xx)
EP (1) EP1530478A2 (xx)
JP (1) JP2003525233A (xx)
KR (1) KR20020084167A (xx)
CN (1) CN1213755C (xx)
AU (1) AU2001254652A1 (xx)
BR (1) BR0108951A (xx)
CA (1) CA2401041A1 (xx)
CZ (1) CZ20022981A3 (xx)
EA (1) EA005413B1 (xx)
EE (1) EE200200479A (xx)
GB (1) GB0005257D0 (xx)
HR (1) HRP20020716A2 (xx)
HU (1) HUP0301123A3 (xx)
MX (1) MXPA02008574A (xx)
NO (1) NO20023971D0 (xx)
NZ (1) NZ521315A (xx)
PL (1) PL358542A1 (xx)
SK (1) SK11902002A3 (xx)
WO (1) WO2001064193A2 (xx)
ZA (1) ZA200207260B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8986501A (en) * 2000-09-08 2002-03-22 Pharmacia & Upjohn Spa Exemestane as chemopreventing agent
LT2269604T (lt) 2001-02-19 2016-11-10 Novartis Ag Inkstų solidinių navikų gydymas rapamicino dariniu
ATE340580T1 (de) * 2003-05-22 2006-10-15 Pantarhei Bioscience Bv Verwendung von zusammensetzungen enthaltend ein oestrogen zur behandlung und verhinderung von muskelskelettschmerzen
WO2005027916A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
DE102006008074B4 (de) * 2006-02-22 2013-08-14 RUHR-UNIVERSITäT BOCHUM Behandlung von Krebs mit Geruchsrezeptor-Liganden
CN101468023B (zh) * 2007-12-26 2011-02-02 上海复星医药(集团)股份有限公司 依西美坦片及其制备工艺
KR200450538Y1 (ko) * 2008-05-29 2010-10-11 최용희 보자기형배낭
MD36Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare
MD23Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
MD35Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
MD24Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones

Also Published As

Publication number Publication date
CA2401041A1 (en) 2001-09-07
PL358542A1 (en) 2004-08-09
EA200200943A1 (ru) 2003-02-27
US20030144259A1 (en) 2003-07-31
NO20023971L (no) 2002-08-21
SK11902002A3 (sk) 2003-05-02
CN1213755C (zh) 2005-08-10
HUP0301123A2 (hu) 2003-08-28
EA005413B1 (ru) 2005-02-24
EP1530478A2 (en) 2005-05-18
JP2003525233A (ja) 2003-08-26
CN1407896A (zh) 2003-04-02
HRP20020716A2 (en) 2003-12-31
AU2001254652A1 (en) 2001-09-12
NZ521315A (en) 2008-10-31
KR20020084167A (ko) 2002-11-04
WO2001064193A2 (en) 2001-09-07
ZA200207260B (en) 2003-09-10
MXPA02008574A (es) 2003-05-01
BR0108951A (pt) 2002-11-26
NO20023971D0 (no) 2002-08-21
CZ20022981A3 (cs) 2003-02-12
WO2001064193A3 (en) 2002-07-25
GB0005257D0 (en) 2000-04-26
HUP0301123A3 (en) 2007-10-29
HK1053424A1 (en) 2003-10-24

Similar Documents

Publication Publication Date Title
EP1392818A4 (en) FOR THE TREATMENT OF CANCER DISEASES IN HUMAN CERTAIN IMMUNE RECEPTOR
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
EE05073B1 (et) Retigabiin kasutamiseks neuropaatilise valu ravis
KR100695846B9 (ko) 암 치료
IL158273A0 (en) Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer
EE200100370A (et) Teraapias kasutatavad spirofuropüridiinide uued aralküülamiinid
IL150628A0 (en) Use of lipid conjugates in the treatment of disease
DE60138611D1 (de) Synergistische kombinationstherapie zur krebsbehandlung
ATE307601T1 (de) Brustkrebsbehandlung mittels natürlicher ätherischer öle
NL300337I1 (nl) Gebruik van et-743 in combinatie-therapie met dexamethasone voor de behandeling van kanker
PL365244A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
NO20042035L (no) Forbedret anvendelse av antitumorforbindelse i kreftterapi
AU2003212634A8 (en) Compounds useful in the treatment of cancer
PL356784A1 (pl) Substancja do zastosowania w leczeniu łuszczycy
EP1320376A4 (en) TREATMENT OF PROSTATE CANCER
DE60223576D1 (de) Hautbehandlungszusammensetzung
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
HUP0300339A3 (en) Use of fulvestrant in the treatment of resistant breast cancer
EE200200479A (et) Eksemestaani kasutamine rinnavähi ravis
AU9279601A (en) Compounds and methods for use thereof in the treatment of cancer or viral infections
DE60222664D1 (de) Hautbehandlungsmittel
PL366066A1 (pl) Kompozycje oraz sposoby leczenia i diagnozowania raka sutka
NO20014725D0 (no) Forbedret kreftbehandling med temozolomid